GnRH antagonists are safer than agonists: an update of a Cochrane review.
about
Comparison of different stimulation protocols used in in vitro fertilization: a reviewStrategies for improving outcome of assisted reproduction in women with polycystic ovary syndrome: systematic review and meta-analysisHuman chorionic gonadotrophin priming for fertility treatment with in vitro maturation.GnRH antagonist for patients with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer in fresh cycles.Oxidative Stress Markers in GnRH Agonist and Antagonist Protocols in IVF.Outcome of cryopreserved-thawed embryo transfer in the GnRH agonist versus antagonist protocolA randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression.Cumulus cells gene expression profiling in terms of oocyte maturity in controlled ovarian hyperstimulation using GnRH agonist or GnRH antagonist.GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.Spontaneous bacterial peritonitis complicating ovarian hyperstimulation syndrome-related ascites.Ovarian hyperstimulation syndrome: a clinical report on 4894 consecutive ART treatment cycles.Preovulatory Aging In Vivo and In Vitro Affects Maturation Rates, Abundance of Selected Proteins, Histone Methylation Pattern and Spindle Integrity in Murine Oocytes.A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cyclesAssessing the optimal dose for Cetrorelix in Chinese women undergoing ovarian stimulation during the course of IVF-ET treatment.Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols.Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation.Evidence-based management of infertility in women with polycystic ovary syndrome using surgery or assisted reproductive technology.The treatment of infertility in polycystic ovary syndrome: a brief update.The extrapituitary effects of GnRH antagonists and their potential clinical implications: a narrated review.Elective Single Embryo Transfer: an update to UK Best Practice Guidelines.Assisted reproductive techniques after fertility-sparing treatments in gynaecological cancers.Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin-releasing hormone agonist and antagonists, on follicular fluid stem cell factor and serum urocortin 1 levels on the day of oocyte retrieval.In vitro fertilization stimulation protocol for normal responder patients.A short course of metformin does not reduce OHSS in a GnRH antagonist cycle for women with PCOS undergoing IVF: a randomised placebo-controlled trial.Comparison of GnRH agonist and antagonist protocols in normoresponder patients who had IVF-ICSI.Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.The gonadotropin-releasing hormone antagonist protocol--the protocol of choice for the polycystic ovary syndrome patient undergoing controlled ovarian stimulation.Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome
P2860
Q26799866-8D65021E-1A16-465C-A8A9-CA93891BAC6FQ28070299-204293F2-7F0E-440E-8C7F-5DD021009867Q30241191-D7974792-F550-4003-8D12-D0C7B22130D1Q33744049-FE9993A4-EF15-4D44-BDC8-9B800D452733Q33801073-83FCEC34-5671-4A2E-83B1-A47B96C520FAQ34196524-6CD423E4-3807-46FB-9C22-C2E94D8C3A26Q34339901-F543896E-B6B1-4AB6-BC12-E21B020B27A7Q34451981-2CB5405C-9553-4E40-BC43-831569C1FAF8Q34636679-DDDB82B8-B134-4995-8479-70A719443E0DQ35580263-00D6C370-8DB9-46CF-8441-DDE2D00AFFB5Q35769428-5E43E8DF-4BFB-4DFA-9CDE-359D5E8A1D76Q36128427-02A58599-11B2-412F-B0D0-093DC4696DE5Q36434666-67EAFA95-B386-47EC-83B5-86093012DD4FQ37369079-A3281BB9-CCAE-4F9F-89AB-5B97EAA5901DQ37370067-6A2795A8-71A1-4F27-B26E-0203206F4AFDQ37429879-FCFA3FC5-09D6-47F1-ACC2-8699697AC033Q38007201-752BCE34-C04F-4E76-8558-81E7748F695DQ38013766-4E5D1046-01EE-4EA4-A818-0193553F3E69Q38046587-7DD46976-4B9E-4CF1-8FEE-BB94BFFD1ABAQ38590592-45843BE8-ACEA-4B40-964A-1EC970024902Q38694178-CAD0ED1A-364C-4F21-8E29-0FDDC919A6BBQ43461931-AFB438B0-B3EB-4C99-AB14-1765EA3DADC4Q44602416-F6E54868-37AD-49E2-880E-7B6B57A33A39Q48536578-3D0985D6-A6E4-48BD-8AE1-9C4E90639D3FQ48624304-FEB39DF2-DF8C-4EC1-8AE1-A7F121483C8DQ48647282-2ABB457A-8749-41BA-BD47-FAF24CEC3832Q48653020-192180FE-FA12-447E-9977-814994CBED7FQ58701046-620C4802-4BDF-4EA8-BC3B-104B39E208F1
P2860
GnRH antagonists are safer than agonists: an update of a Cochrane review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@en
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@nl
type
label
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@en
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@nl
prefLabel
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@en
GnRH antagonists are safer than agonists: an update of a Cochrane review.
@nl
P2093
P356
P1476
GnRH antagonists are safer than agonists: an update of a Cochrane review
@en
P2093
Ahmed M Abou-Setta
Frank Broekmans
Hesham G Al-Inany
Janine Smit
Mohamed A F M Youssef
Mohamed Aboulghar
P356
10.1093/HUMUPD/DMR004
P577
2011-07-01T00:00:00Z